Targeting PI3K in cancer: mechanisms and advances in clinical trials
Jing Yang(Harbin Medical University), Xiawei Wei(Sichuan University)
Cited by 1,551
Related Papers
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
|Signal Transduction and Targeted Therapy|2019|1.1k
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
|Journal of Hematology & Oncology|2022|964
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|845
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
|Journal of Hematology & Oncology|2022|687
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
|Journal of Hematology & Oncology|2022|575